GlassScriptPhysician profile
Phyllis G Grable Esposito
NPI 1922134634
$8,838.46
in general payments reported to CMS, 2019-2025
58 companies · $1,577 in 2025
The $1,577 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,709 · 2020: $525 · 2021: $274 · 2022: $859 · 2023: $1,199 · 2024: $1,696 · 2025: $1,577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,392 · Education: $79.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,391.81 |
| Education | $79.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $928.90 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $763.19 | 2019-2025 | |
| Pfizer INC. | $547.79 | 2023-2025 | |
| Amgen INC. | $542.79 | 2019-2025 | Uplizna, Repatha |
| Emd Serono, INC. | $408.77 | 2019-2025 | Mavenclad |
| Ucb, INC. | $387.82 | 2019-2025 | Rystiggo, Nayzilam, Briviact |
| Teva Pharmaceuticals USA, INC. | $319.31 | 2019-2020 | |
| Genzyme Corporation | $286.01 | 2019-2025 | |
| Biogen, INC. | $263.94 | 2019-2024 | Vumerity |
| Allergan, INC. | $263.77 | 2019-2021 | |
| Sk Life Science, INC. | $213.09 | 2022-2025 | |
| Lundbeck LLC | $193.18 | 2024-2025 | Vyepti |
| Eisai INC. | $186.81 | 2020-2025 | |
| Tg Therapeutics, INC. | $186.04 | 2023-2025 | |
| Celgene Corporation | $169.86 | 2022-2024 | Zeposia |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phyllis Grable Esposito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.